February 12, 2020 / 9:21 PM / in 11 days

BRIEF-Deciphera Pharmaceuticals Announces U.S. Food And Drug Administration Acceptance Of New Drug Application And Priority Review For Ripretinib

Feb 12 (Reuters) - Deciphera Pharmaceuticals Inc:

* DECIPHERA PHARMACEUTICALS ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION ACCEPTANCE OF NEW DRUG APPLICATION AND PRIORITY REVIEW FOR RIPRETINIB IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS

* DECIPHERA PHARMACEUTICALS INC - FDA GRANTS PRIORITY REVIEW AND SETS PDUFA DATE OF AUGUST 13, 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below